Cahill Represents Initial Purchasers in $1 Billion Notes Offering for Bausch Health Companies Inc.
Date: 02/10/22
Cahill represented the initial purchasers in connection with a Rule 144A offering of $1,000,000,000 aggregate principal amount of 6.125% senior secured notes due 2027 by Bausch Health Companies Inc., a multinational specialty pharmaceutical company. Proceeds from the offering will be used, along with the expected proceeds from certain new term b loans, the Bausch + Lomb initial public offering and the repayment of certain intercompany debt, to refinance certain existing indebtedness and to pay related fees, premiums and expenses.